Australian biotech BioDiem Ltd. says it is testing a vaccine that could provide broad protection against influenza, including the H5N1 avian flu virus. The vaccine has passed Phase I trials in Russia, and a positive response has spurred the maker to begin the next phases later this year.

Related Summaries